Mark T. Leibowitz
Mark T. Leibowitz publishes mostly in Infectious Diseases, Pharmacology and Psychiatry and Mental health, on topics such as SARS-CoV-2 and COVID-19 Research, Immune responses and vaccinations and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #1,984,838 of 7,710,434 ranked researchers
- Rank in United States
- #603,135 of 1,627,098
- Works
- 30
- Citations
- 1.1k
- Citations per work
- 35.2
What does Mark T. Leibowitz research?
Mark T. Leibowitz's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (7%), Psychology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1858.4%
- Health Sciences929.7%
- Medicine929.7%
- Life Sciences27.1%
- Social Sciences14.8%
- Psychology14.8%
- 1Infectious Diseases10% of their works
- 2Pharmacology7% of their works
- 3Psychiatry and Mental health7% of their works
- 4Molecular Biology7% of their works
- 5Cardiology and Cardiovascular Medicine6% of their works
- 6Experimental and Cognitive Psychology5% of their works
Research topics
Which keywords describe Mark T. Leibowitz's research?
The keywords of their largest research topics: Coronavirus, SARS-CoV-2, Machine Learning, Acetylcholinesterase, Cholinesterase Inhibitors, Innate Memory, Trained Immunity and cAMP Signaling.
- Virtual Screening
- Pain Management
- Molecular Docking
- Educational Data Mining
- Cancer Pain
- Innate Memory
- Acetylcholinesterase
- SARS-CoV-2
- Coronavirus
- Machine Learning
- Cholinesterase Inhibitors
- Trained Immunity
- Cyclic Nucleotide Phosphodiesterases
- Learning Analytics
- Neurotransmission
- Synaptic Plasticity
- cAMP Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Coronavirus51 topic
- SARS-CoV-251 topic
- Machine Learning42 topics
- Acetylcholinesterase31 topic
- Cholinesterase Inhibitors31 topic
- Innate Memory31 topic
- Trained Immunity31 topic
- Cancer Pain21 topic
- Cyclic Nucleotide Phosphodiesterases21 topic
- Educational Data Mining21 topic
- Learning Analytics21 topic
- Molecular Docking21 topic
- Neurotransmission21 topic
- Pain Management21 topic
- Synaptic Plasticity21 topic
- Virtual Screening21 topic
- cAMP Signaling21 topic
Where does Mark T. Leibowitz work?
Mark T. Leibowitz's main affiliation in the publication record is Los Angeles Clinical Trials, United States.
How many publications and citations does Mark T. Leibowitz have?
OpenAlex counts 30 works and 1,057 citations for Mark T. Leibowitz, an h-index of 16, ranking #1,984,838 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark T. Leibowitz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.